GC Biopharma announced on Monday that operating profit for the second quarter of 2022 jumped by 18 percent on year recording 13.1 billion won ($10 million).Sales stood at 423.2 billion won in the second quarter, up 9.2 percent year-on-year. Net profit jumped 45.3 percent to 10.9 billion won in the s
Genencell said Tuesday it obtained approval from Drugs Controller General of India (DCGI) to conduct phase 2/3 trial of ES16001 (pipeline name: GNC102), an oral Covid-19 treatment candidate.The biotech firm is conducting Covid-19 drug trials in multiple countries.In October, it received the nod to c
A team of researchers at Asan Medical Centre (AMC) developed a lymphatic channel sheet (LCS) to restore the flow of damaged lymph nodes to prevent lymphedema after cancer treatment.Radiation therapy is often performed to resect the metastasized lymph node and reduce cancer recurrence. At this time,
Samjin Pharmaceutical signed an agreement with Cyclica, a Canadian AI-based novel drug development platform company, for a joint research on AI novel drug development.Under the agreement, Samjin Pharmaceutical will propose several potential drug candidates to Cyclica, and Cyclica will apply its AI-b
Helixmith is facing additional delays in receiving a recommendation from the Independent Data Monitoring Committee (IDMC) for its U.S. phase 3 clinical trial of Engensis (VM202), its diabetic peripheral neuropathy (DPN) treatment.Industry sources said the IDMC interim results could predict whether t
Samsung Biologics said on Tuesday it completed the first engineering run of its one-stop production system for large-scale commercial production of mRNA Covid-19 vaccine raw materials, following the contract manufacturing organization (CMO) for Moderna's mRNA vaccine.Greenlight Bioscience and Samsun
The government has been dragging its feet to review insurance benefits for Roche’s new spinal muscular atrophy (SMA) oral drug Evrysdi (ingredient: risdiplam) for over a year because it wants to review it together with expanded insurance coverage for the existing SMA drug Spinraza (nusinersen), sour
ST Pharm announced on Monday it won the U.S. FDA’s current Good Manufacturing Practice (cGMP) certification for its oligonucleotide (oligo) plant in Korea, for the first time in Asia.An FDA inspection team visited ST Pharm’s oligo factory in Banwol in Ansan in May and conducted a pre-approval inspec
Starting Monday, the government stopped conducting daily health monitoring phone calls to high-risk Covid-19 patient groups, including those over 60 or immunocompromised people undergoing at-home treatment.The government had classified those over 60 and immunocompromised people as the intensive at-h
A research team at St. Mary's Hospital has discovered that T cell, which causes autoimmune liver disease, appears after a liver biopsy on patients who received the Covid-19 vaccine.The research, conducted by Professors Sung Pil-soo at Seoul St. Mary's Hospital and Lee Sun-kyu at Incheon St. Mary's H
The Korea Atomic Energy Research Institute (KAERI) said Monday that its Advanced Radiation Technology Institute has developed a precision prediction model for radiation’s damage to DNA for the first time.By precisely predicting the level of radiation’s damage on DNA, medical professionals can evalua
Novartis Korea said Monday that it released Zolgensma, the nation's first gene replacement treatment for spinal muscular atrophy (SMA), on Monday with the registration of health insurance benefits.SMA is a fatal rare genetic disease and one of the main causes of infant death, in which muscles gradua
Almost half of 125 Korean clinics and hospitals have expanded their operations in China so far, and more than a third of them were in the dermatology and plastic surgery fields, a report showed.The Korea Health Industry Development Institute (KHIDI) released a report on Korean medical institutions’
Celltrion began the domestic sale of its Alzheimer's dementia treatment, Donerion Patch (ingredient name: donepezil), on Monday.Donerion, the first patch-type donepezil-based dementia treatment worldwide, received approval from the Ministry of Food and Drug Safety (MFDS) in November and began to get
Becton Dickinson (BD) Korea said it has completed Bard Korea's acquisition and integrated its Korean legal entity into BD Korea from Monday.BD, a global medical technology company, acquired Bard for $24 billion in 2017. However, the two companies have been operating as independent corporations in Ko
Patients with nervous system disorders such as stroke and cerebral hemorrhage need intensive treatment in the “golden hour.” To do so, hospitals need to increase the number of neurointensivists within the intensive care units (ICUs), an expert said.More than half of the patients in ICUs at tertiary
Korea’s bio-industry is experiencing rapid growth, and the medical AI industry is no exception.Few other companies illustrate this trend better than medical AI startup VUNO. Since its founding in 2014, the company has quickly transformed into an international name.However, despite Korea’s increasing
Eli Lilly Korea said Monday that it has appointed Christopher J. Stokes, general manager at Eli Lilly South Africa and Sub Saharan Africa, as its new general manager.The current general manager, Alberto Riva, has been appointed as the head of Eli Lilly Brazil.Stokes, who first joined Eli Lilly's U.S
LG Chem said it is in the final stage of entering the global gout treatment market.LG Chem applied for a phase 3 clinical trial of Tigulixostat, a self-developed novel gout treatment, to the U.S. Food and Drug Administration on Monday. It marked the first time the company applied for a phase 3 clini
In the wake of the Covid-19 pandemic, violence against healthcare professionals increased by 58 percent worldwide, a report showed.Verbal and physical attacks on physicians, nurses, and medical service workers occurred in all regions of the world. Emergency care and operating rooms were also exposed